Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C43H63NO11 |
| Molecular Weight | 769.9604 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1C[C@H](O[C@H]2[C@@H](C)\C=C\C=C3/CO[C@@H]4\C(=N/O)C(C)=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)O[C@@H](C)[C@@H]1O
InChI
InChIKey=AFJYYKSVHJGXSN-XHKIUTQPSA-N
InChI=1S/C43H63NO11/c1-24-11-10-14-30-23-50-40-36(44-48)27(4)19-33(43(30,40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-12-8-7-9-13-29/h10-11,14-15,19,24,26,28-29,31-35,37-40,45,47-48H,7-9,12-13,16-18,20-23H2,1-6H3/b11-10+,25-15+,30-14+,44-36-/t24-,26-,28-,31+,32-,33-,34-,35-,37-,38-,39-,40+,42+,43+/m0/s1
| Molecular Formula | C43H63NO11 |
| Molecular Weight | 769.9604 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.fda.gov/downloads/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm117201.pdfCurator's Comment: Description was created using several sources including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8032a1ae-d192-4514-80f1-9a3b50dc2155;
http://www.wipo.int/research/en/details.jsp?id=1502;
https://www.zoetis.co.za/_locale-assets/pdf/revolution.pdf; http://www.ncbi.nlm.nih.gov/pubmed/19032763
Sources: http://www.fda.gov/downloads/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm117201.pdf
Curator's Comment: Description was created using several sources including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8032a1ae-d192-4514-80f1-9a3b50dc2155;
http://www.wipo.int/research/en/details.jsp?id=1502;
https://www.zoetis.co.za/_locale-assets/pdf/revolution.pdf; http://www.ncbi.nlm.nih.gov/pubmed/19032763
Selamectin (trade name Revolution, Stronghold) is a broad-spectrum endectocide. It is used in dogs and cats for treatment, control and prevention against fleas, heartworms, ear mites, ticks and other parasites. Selamectin is not approved for human use. It is a a semi-synthetic compound of the avermectin class, a macrocyclic lactone.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=19161460
Curator's Comment: Brain penetration of selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. | 2009-02 |
|
| Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. | 2007-01 |
|
| Multimodal approach to treatment for control of fur mites. | 2006-07 |
Patents
Sample Use Guides
The recommended minimum dose for cats and dogs of six weeks of age and older is 2.7 mg selamectin per pound (6 mg/kg) of body weight as a single dose.
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=17134887
Curator's Comment: Interaction of selamectin with P-glycoprotein was studied on on membrane vesicles prepared from fibroblasts overexpressing P-glycoprotein.
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:14:47 GMT 2025
by
admin
on
Mon Mar 31 18:14:47 GMT 2025
|
| Record UNII |
A2669OWX9N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA VETERINARY ASSESSMENT REPORTS |
STRONGHOLD [AUTHORIZED ]
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
STRONGHOLD PLUS [AUTHORIZED ]
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
||
|
WHO-VATC |
QP54AA05
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
STRONGHOLD [AUTHORIZED ]
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
||
|
CFR |
21 CFR 524.2098
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1044269
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | RxNorm | ||
|
A2669OWX9N
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
m9831
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB11459
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
9578507
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
1611729
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
165108-07-6
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
C75233
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
C414354
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
Selamectin
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
JJ-88
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
CHEMBL1908325
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
DTXSID6045903
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
300000023777
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
selamectin
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
A2669OWX9N
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
220119-17-5
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY | |||
|
7888
Created by
admin on Mon Mar 31 18:14:47 GMT 2025 , Edited by admin on Mon Mar 31 18:14:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|